COLO and WiDr cells were significantly resistant to doxorubicin as compared to wt p53 SW48 colon cancer cells, or MCF-12A noncancerous epithelial cells (Figure 1A left-panel). This evidence concerns the gene TP53 and colonic neoplasm.